"HIV/AIDS : ÊÒ¾ѹ¸ØìãËÁè??? "01.07.06
1."Evaluation of Anti-HIV-1 Immunity: from Basic Science Toward HIV-1 Vaccine Clinical Trial in Thailand"
2. HIV vaccine 01/10/02
3. ÇÔ¸ÕÇÔ¹Ô¨©Ñ·ҧͳ٢ͧ¡ÒõԴàª×éÍàͪäÍÇÕ MOLECULAR DIAGNOSTIC OF HIV INFECTION24/09/02
4. rgp41 ELISA18/09/02
5.Diversity of HIV-1 subtype E in semen and cervicovaginal secretion16/09/02
6.Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants12/09/02 7. Overview of HIV Vaccine Candidates that Elicit CTL Responses 06/06/2001 (powerpoint presentation)
8.Generation of tailored CTL targets with VSV-pseudotyped HIV-1 01/06/2001
9. Propagation and Maintenance of the B95-8 Cell Line for EBV Production and Transformation of B Lymphoblastoid Cells 31/05/2001
10.Enzyme-linked Immuno Spot.( ELIspot ) 29/05/2001
11. CTL Response in Open Label Volunteers Enrollment in Prime Boost Subtype E Vaccine Trial in Thailand. 28/05/2001
12. HIV-Specific Cellular Immune Response in Highly-exposed Persistently Seronegative Women from a Serodiscordant cohort in Chiangmai, Thailand. (powerpoint presentation ) 25/05/2001
13. HIV Vaccine Trial in Thailand. (powerpoint presentation ) 24/05/2001
14. Practical issues involved in conducting large numbers of CTL assays in Thailand.(powerpoint presentation ) 22/05/2001
15. Enhancement Of antigen specific signals in IFN-alpha ELISPOT(powerpoint presentation) 03/05/2001
01.07.06